- Home
- KIND vs KLTOW Comparison
KIND vs KLTOW Comparison
Compare KIND & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIND
- KLTOW
- Stock Information
- Founded
- KIND 2011
- KLTOW N/A
- Country
- KIND United States
- KLTOW United States
- Employees
- KIND N/A
- KLTOW N/A
- Industry
- KIND Computer Software: Programming Data Processing
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KIND Technology
- KLTOW Health Care
- Exchange
- KIND Nasdaq
- KLTOW Nasdaq
- Market Cap
- KIND 974.5M
- KLTOW N/A
- IPO Year
- KIND N/A
- KLTOW 2022
- Fundamental
- Price
- KIND $2.42
- KLTOW $0.03
- Analyst Decision
- KIND Hold
- KLTOW
- Analyst Count
- KIND 2
- KLTOW 0
- Target Price
- KIND $2.75
- KLTOW N/A
- AVG Volume (30 Days)
- KIND 2.3M
- KLTOW N/A
- Earning Date
- KIND 11-06-2024
- KLTOW N/A
- Dividend Yield
- KIND N/A
- KLTOW N/A
- EPS Growth
- KIND N/A
- KLTOW N/A
- EPS
- KIND N/A
- KLTOW N/A
- Revenue
- KIND $237,605,000.00
- KLTOW N/A
- Revenue This Year
- KIND $14.90
- KLTOW N/A
- Revenue Next Year
- KIND $14.61
- KLTOW N/A
- P/E Ratio
- KIND N/A
- KLTOW N/A
- Revenue Growth
- KIND 9.99
- KLTOW N/A
- 52 Week Low
- KIND $1.32
- KLTOW N/A
- 52 Week High
- KIND $3.00
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- KIND 41.53
- KLTOW N/A
- Support Level
- KIND $2.26
- KLTOW N/A
- Resistance Level
- KIND $2.68
- KLTOW N/A
- Average True Range (ATR)
- KIND 0.13
- KLTOW 0.00
- MACD
- KIND -0.03
- KLTOW 0.00
- Stochastic Oscillator
- KIND 16.04
- KLTOW 0.00
About KIND Nextdoor Holdings Inc.
Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.